Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The oral Wegovy pill offers the identical active ingredient in a daily tablet for those preferring non-injection methods
Clinical evidence : A study published in the journal "Diabetes Care" showed that dulaglutide demonstrated improvements in glycemic control without increasing the risk of adverse events when compared to sitagliptin, a DPP-4 inhibitor (source: "Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial" - PubMed Central)
A review on patient diet management for chronic kidney disease based on clinical trials
At Centra Internal Medicine, we understand that beginning a medical weight loss journey comes with many questions regarding expectations and timelines
